Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT00787436
First received: November 5, 2008
Last updated: July 29, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: January 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)